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Abstract 
Zymogen granules (ZG) are specialized organelles in the exocrine pancreas which allow 
digestive enzyme storage and regulated secretion. The molecular mechanisms of their 
biogenesis and the sorting of zymogens are still incompletely understood. Here, we 
investigated the role of proteoglycans in granule formation and secretion of zymogens in 
pancreatic AR42J cells, an acinar model system. Cupromeronic Blue cytochemistry and 
biochemical studies revealed an association of proteoglycans primarily with the granule 
membrane. Removal of proteoglycans by carbonate treatment led to a loss of membrane 
curvature indicating a supportive role in the maintenance of membrane shape and stability. 
Chemical inhibition of proteoglycan synthesis impaired the formation of normal electron-
dense granules in AR42J cells and resulted in the formation of unusually small granule 
structures. These structures still contained the zymogen carboxypeptidase, a cargo molecule 
of secretory granules, but migrated to lighter fractions after density gradient centrifugation. 
Furthermore, the basal secretion of amylase was increased in AR42J cells after inhibitor 
treatment. In addition, irregular-shaped granules appeared in pancreatic lobules. We conclude 
that the assembly of a proteoglycan scaffold at the ZG membrane is supporting efficient 
packaging of zymogens and the proper formation of stimulus-competent storage granules in 
acinar cells of the pancreas.  
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Introduction 
Pancreatic acinar cells are specialised in the synthesis, sorting, storage and regulated secretion 
of a complex mixture of digestive enzymes, which are packaged in a condensed and mainly 
inactive form into zymogen granules (ZG). These large, highly abundant secretory organelles 
are stored at the apical pole of the acinar cells and release their cargo via exocytosis in a 
regulated, calcium-dependent manner triggered by neuronal or hormonal stimulation. The 
secreted digestive enzymes reach the small intestine via the pancreatic duct system, where 
they are activated by enterokinase through proteolytic cleavage of trypsinogen. 
The formation of ZG in the acinar cells is initiated at the trans-Golgi network (TGN) 
where the regulated secretory ZG proteins co-aggregate at the mildly acidic pH and high 
calcium levels and immature secretory granules, so called condensing vacuoles, are formed 
(Colomer et al. 1996, Dartsch et al. 1998, Freedman & Scheele 1993, Leblond et al. 1993). 
They mature by further concentration of the cargo proteins with selective removal of 
components not destined for regulated secretion. However, the molecular mechanisms of ZG 
formation and sorting of zymogens are still incompletely understood (Borgonovo et al. 2006, 
Dikeakos & Reudelhuber 2007, Gómez-Lázaro et al. 2010, Schmidt et al. 2001, Schrader 
2004). This also applies to the regulation and maintenance of the size and the shape of the 
relatively large ZG (up to 1 µm in diameter). Using pancreatic AR42J cells, an acinar model 
system, we recently demonstrated that expression of ZG cargo proteins is not sufficient to 
trigger granule formation (Rinn et al. 2012). This is in line with previous reports indicating 
that specific accessory molecules are required for proper ZG formation. These components 
include helper proteins for cargo aggregation (de Lisle et al. 2005, Kleene et al. 1999) and/or 
components of the granule membrane (Colomer et al. 1996, Leblond et al. 1993, Schmidt et 
al. 2001, Schrader 2004). The latter enclose sulfated proteoglycans, which have been 
identified in ZG and in the fluid of the pancreatic ductal system (Berg & Young 1971, Reggio 
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& Palade 1978, Tartakoff et al. 1975). The negatively charged proteoglycans in secretory 
granules of hematopoietic cells and mast cells are involved in the binding of small positively 
charged molecules, such as amines and proteases, and have therefore been considered to 
promote the efficient storage of secretory products (Rönnberg et al. 2012, Wernersson & 
Pejler 2014). Similarly, proteoglycans within ZGs have been proposed to support ZG 
biogenesis and to concentrate at the ZG membrane (Kleene et al. 1999, Scheele et al. 1994, 
Schmidt et al. 2000, Schrader 2004), but their role in ZG formation is unclear. 
In recent proteomics studies, new ZG components have been identified, which are known 
to interact with proteoglycans in other systems (Borta et al. 2010, Chen et al. 2008).These 
include chymase, a major, highly basic chymotrypsin-like serine protease initially identified 
in mast cells, and PpiB (Cyclophilin B), a highly basic cyclosporin A-binding protein with 
peptidyl-prolyl cis-trans isomerase activity (Allain et al. 2002, Borta et al. 2010). In addition, 
well-known constituents of ZG such as RNAse A and carboxyl ester lipase (CEL) have the 
potential to interact with proteoglycans, e.g. to influence enzyme function (Dvorak & Morgan 
1998, Rebaï et al. 2005). Moreover, an interaction of the secretory lectin ZG16p (Cronshagen 
et al. 1994, Kleene et al. 1999) with heparan sulfate containing proteoglycans from ZG has 
recently been reported (Kumazawa-Inoue et al. 2012). 
To elucidate the role of proteoglycans in exocrine granule formation, we have exploited 
pancreatic AR42J cells, an exocrine model system. Our data show that proteoglycans are 
mainly present attached to the granule membrane and indicate an important function in the 
maintenance of membrane shape and stability. After inhibition of proteoglycan synthesis by 
β-D xyloside normal granule formation was impaired. Furthermore, the basal secretion of 
amylase was increased. We conclude from these findings that the assembly of a proteoglycan 
scaffold at the ZG membrane is supporting efficient packaging of zymogens and the proper 
formation of stimulus-competent storage granules in acinar cells of the pancreas. 
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Materials and methods 
Antibodies 
Antibodies were used as follows: rabbit polyclonal antibodies against amylase (Sigma-
Aldrich, St. Louis, MO), carboxypeptidase A (Rockland Immunochemicals, Gilbertsville, 
PA), ZG16p (Cronshagen et al. 1994), mouse monoclonal antibodies directed to GP2 (kindly 
provided by A. Lowe, Stanford University School of Medicine, Palo Alto, CA), tubulin 
(Sigma) and p115 (BD Transduction Lab.). A polyclonal antibody raised against components 
of a carbonate extract from isolated ZGM (anti-membrane-matrix) is described elsewhere 
(Schmidt et al. 2000). Species-specific anti-IgG antibodies conjugated to the fluorophores 
TRITC and Alexa 488 were obtained from Jackson ImmunoResearch (West Grove, PA), and 
Invitrogen (Carlsbad, CA). Species-specific IgG antibodies conjugated to HRP were obtained 
from BioRad (Richmond, CA). 
 
Cell culture, drug treatment and secretion experiments 
AR42J cells (ATCC no. CRL-1492) were maintained in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin and 10% fetal calf 
serum (PAA Laboratories GmbH, Linz, Austria) (Faust et al. 2008) at 37°C in a humidified 
atmosphere containing 5% CO2. To improve cell adherence of AR42J cells, culture dishes 
and coverslips were coated with an extract of Engelbreth-Holm-Swarm tumor, prepared 
according to (Kleinman et al. 1979). To induce differentiation and zymogen granule 
formation, AR42J cells were incubated with 10 nM dexamethasone for 2-3 days (Swarovsky 
et al. 1988). Cell numbers and viability were determined by Trypan Blue staining in a Fuchs-
Rosenthal chamber. Proteoglycan synthesis was inhibited by 4-methylumbilliferyl-β-D-
xyloside (β-D-xyloside) (Sigma), which was dissolved in dimethyl sulfoxide (DMSO) 
(Sigma). Cells were pre-treated with the inhibitor (0-2.5 mM) or with DMSO for 4 hours 
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before granule formation was induced by the addition of 10 nM dexamethasone. After 48 
hours cells were processed for indirect immuofluorescence, electron microscopy or for 
biochemical studies. Cell viability after 48 hours of treatment with β-D-xyloside was 
comparable to untreated controls (not shown).  
Amylase secretion assays were adapted from (Limi et al. 2012). AR42J cells were seeded 
in 6 cm culture dishes in complete DMEM culture medium (see above) and treated with 10 
nM dexamethasone. After 2 days the cells were washed twice with PBS and incubated with 
Krebs-HEPES buffer (KHB) (140 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 15 mM HEPES, 
10 mM glucose, 2.5 mM CaCl2, 0.1 mM PMSF, 2.5 mM Aprotinin, pH 7.4) without or with 
1.5 nM cholecystokinin octapeptide 26-33 (CCK-8) (Sigma) for 30 min. After incubation the 
buffer was removed and centrifuged for 2 minutes at 16,000g to remove cellular debris. The 
cells were collected in fresh KHB and lysed by forcing them through a 26G - gauge needle 
followed by brief sonication. Amylase activity in buffers and cells was measured with the 
Liquick Cor-AMYLASE diagnostic kit (PZ Cormay, Poland). Amylase release was 
determined as the percentage of amylase activity secreted into KHB (with or without CCK-8) 
over the 30 min incubation in relation to total amylase. 
 
Subcellular fractionation 
AR42J cells were treated with β-D-xyloside and DMSO as described above. After 48 hours 
cells were homogenized with a Potter S homogenizer (1000 rpm, 2 strokes) in 
homogenization buffer (see below). The post nuclear supernatant (500g, 5 min, 4ºC) was 
applied on top of a continuous OptiPrep gradient (0-30%) (Axis-Shield, Oslo, Norway). 
After centrifugation at 20,000g for 3.5 hours at 4°C in a swing-out rotor (SW41, Beckman 
Instruments, Munich, Germany), fractions (500 µl) were collected from the top of the 
gradient. Proteins were precipitated by 10% TCA and analyzed by SDS-PAGE. 
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Isolation of zymogen granules from rat pancreas 
Zymogen granules (ZG) were isolated as described previously (Borta et al. 2010) from the 
pancreas of male Wistar rats (200-230 g) (Charles River, Sulzfeld, Germany). Animals were 
handled according to the German law for the protection of animals, with the permit of the 
local authorities. The following buffer was used for homogenization: 0.25 M sucrose, 5 mM 
2-N-morpholino-ethanesulfonic acid (MES), pH 6.25, 0.1 mM MgSO4, 1 mM dithiothreitol, 
10 µM Foy-305 (Sanol Schwarz, Monheim, Germany), 2.5 mM Trasylol (Bayer, Leverkusen, 
Germany), 0.1 mM phenylmethylsulfonyl fluoride. ZGs were resuspended in 50 mM N-2-
hydroxyethylpiperazine-N-ethanesulfonic acid (HEPES), pH 8.0, and lysed by freezing and 
thawing. The zymogen granule membrane (ZGM) was separated from the soluble zymogen 
granule content proteins (ZGC) by ultracentrifugation (100,000g for 30 minutes), resuspended 
in 50 mM HEPES, pH 8.0 and stored at -20°C. For some experiments, ZGM were pre-
incubated with enterokinase. For carbonate treatment ZGM were incubated with the same 
volume of 300 mM Na2CO3, pH 11.5 on ice for 2 hours and recovered by high-speed 
centrifugation at 100,000g for 30 minutes.  
 
Gel electrophoresis and immunoblotting 
Protein concentrations were determined using the Bradford assay or the BCA reagent kit 
(Interchim, Montlucon, France). Proteins were precipitated with 10% (w/v) trichloracidic acid 
(TCA) and boiled in SDS-PAGE sample buffer. Protein samples were separated by SDS-
PAGE on 12.5% polyacrylamide mini gels, transferred to nitrocellulose (Schleicher and 
Schüll, Dassel, Germany) via a semi-dry apparatus (Trans-Blot SD, Biorad) and analysed by 
immunoblotting using horseradish peroxidase-conjugated secondary antibodies and enhanced 
chemiluminescence reagents (Amersham Bioscience, Arlington Heights, IL, USA).  
 
Biochemical assays 
Aroso et al. 8 
Sulfated proteoglycans and glycosaminoglycans were determined using the Blyscan assay 
according to the manufacter's protocol (Biocolor, Belfast, Ireland). Briefly, equal amounts of 
TCA-precipitated protein were resuspended in 50 mM HEPES, pH 8.0 and incubated with the 
Blyscan dye. A precipitable complex was formed by binding of the dye to sulfated 
proteoglycans and glycosaminoglycans. After dissociation of the precipitated complex the 
samples were photometrically quantified. Agarose gel analysis of proteoglycans was 
performed according to (Metkar et al. 2002). Zymogen granule subfractions were run on a 1% 
agarose gel prepared and run in Tris-Borate-EDTA buffer, pH 8.3, followed by staining with 
0.02% toluidine blue in 3% acetic acid and destaining in 3% acetic acid. Biglycan from 
bovine articular cartilage (Sigma) and chondroitin sulfate (Sigma) were used as standards.  
 
Immunofluorescence and microscopy 
Cells grown on glass coverslips were fixed with 4% para-formaldehyde in PBS, pH 7.4 for 20 
minutes at RT. The samples were permeabilised with 0.2% Triton X-100 (10 minutes, RT), 
blocked with 1% BSA (15 minutes, RT) and incubated with primary and secondary antibodies 
(1 hour each, RT) as described (Borta et al. 2010, Faust et al. 2008). Samples were examined 
using an Olympus IX-81F microscope (Olympus Optical Co. LTD Tokyo, Japan) equipped 
with the appropriate filter combinations and a 100x objective (Olympus PlanApo; numerical 
aperture, 1.4). Fluorescence images were acquired with an F-view II CCD camera (Soft 
Imaging System GmbH, Münster, Germany) driven by Soft imaging software. Digital images 
were optimized for contrast and brightness using Adobe Photoshop (Adobe Systems, USA). 
 
Preparation of pancreatic lobules 
Pancreatic lobules were prepared as described (Scheele & Palade 1975) from animals fed with 
a single dose of 50 mg/kg of FOY-305 (Sanol-Schwarz, Mohnheim, Germany) dissolved in 1 
ml of tap water (Schmidt et al. 2001). FOY treatment for up to 6 hours results in partial 
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degranulation (40-60%) of the pancreas (Rausch et al. 1987). The lobules were incubated at 
37°C under agitation and were supplied with 100% O2 every 15 minutes. For inhibition of 
proteoglycan synthesis lobules were incubated for 3 hours in 5 ml MEM (Sigma, Munich, 
Germany) containing 2.5 mM β-D-xyloside (Sigma) or DMSO (controls). Treated lobules and 
controls were processed for electron microscopy. 
 
Electron microscopy 
Proteoglycan staining was performed according to the Cupromeronic Blue (CmB, Seikagaku 
Corp., Tokyo, Japan) procedure at critical electrolyte concentration developed by (Scott 1980, 
1985). Pancreatic tissue was fixed with 1% glutaraldehyde for 30 minutes and stained 
overnight in 25 mM sodium acetate, pH 5.7, containing 0.5% glutaraldehyde, 0.05% CmB 
and 0.3 M MgCl2. AR42J cells were stained for 15-60 minutes. At this electrolyte 
concentration highly sulfated acidic glycosaminoglycan side chains of proteoglycans are 
preferentially stained by CmB (Scott 1985). After three washes in acetate-MgCl2 specimens 
were contrasted with 0.5% sodium tungstate (Scott 1985) in water and in 50% ethanol, 
dehydrated in an ascending series of ethanol and embedded in Epon. For routine electron 
microscopy, pancreatic lobules were fixed with Ito-fixative for 30 minutes at room 
temperature (Faust et al. 2008). AR42J cells were fixed in 1% glutaraldehyde in 0.2M PIPES 
buffer (pH 7.2) for 15 minutes before scraping the cells from the culture dish in a small 
volume of the fixative. The cells were then pelleted (15 minutes at 13.300 x g), washed three 
times in buffer followed by post-fixation for 1 hour at RT in 1% osmium tetroxide containing 
1.5% w/v potassium ferrocyanide to improve membrane contrast. The cells were subsequently 
washed with distilled water and dehydrated through a graded ethanol series followed by 
embedding in Durcupan resin (Sigma Aldrich, Poole, UK). Ultrathin sections (70 nm) were 
collected on pioloform-coated EM copper grids (Agar Scientific, Stansted, UK) and 
contrasted using lead citrate with or without prior staining with 2% w/v aqueous uranyl 
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acetate. Sections were analysed using a JEOL JEM 1400 transmission electron microscope 
operated at 80 kV. Images were obtained with a side mounted Gatan ES1000W digital camera 
(Gatan, Abingdon, Oxon, UK) at a nominal magnification of 50 or 100k X. Isolated granule 
membrane fractions were fixed in 0.1% cacodylate buffer, pH 7.3 containing 1% 
glutaraldehyde (Serva, Heidelberg, Germany). After postfixation with 1% K4Fe(CN)6-reduced 
osmium tetroxide (1 hour at RT), samples were stained with 0.3% uranyl acetate (1 hour at 
4°C). The samples were dehydrated in a graded series of alcohol and embedded in Epon 812 
(Polysciences Ltd., Eppenheim, Germany) according to standard procedures. Thin sections 
(70 nm) were stained with lead citrate and examined using a Zeiss EM 109 electron 
microscope. 
 
Quantitation and statistical analysis of data 
For quantitative analysis of granule morphology in AR42J cells, 100-200 cells per coverslip 
were examined and categorized as ‘granular’ when showing a typical punctate staining pattern 
(see Fig. 4B). Analysis was done blind. Four coverslips per preparation were analyzed, and 4-
6 independent experiments were performed. Quantitative analysis of ultrastructural alterations 
of pancreatic granules after different experimental treatments was performed on EM 
micrographs. Sections were randomly photographed at a magnification of 3000-12000×. The 
results of the quantitative analysis presented were from 3 independent experiments. 
Significant differences between experimental groups were detected by analysis of variance for 
unpaired variables using Microsoft Excel. Data are presented as means ± S.D., with an 
unpaired t-test used to determine statistical differences. P-values <0.05 are considered as 
significant, and p-values <0.01 are considered as highly significant. For estimating granule 
size, AR42J cells were scanned systematic uniform random using the digital camera and a 
systematic graticule with regular spacing which was positioned orthogonal to the scanning 
direction. One edge of the graticule markings was assigned for recording intersections 
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between the graticule scale and the granule profiles and the number of markings crossed by 
each granule during the scan was counted. For selecting the granules for sizing an unbiased 
counting band was used during the scan with one edge of the band defined as an acceptance 
line, the other as the forbidden line (Gundersen 1977). Granules that translocated within the 
band or crossing the acceptance line were selected for sizing. Granule sizes were estimated by 
multiplying the number of intersections and the spacing between the graticule markings. 
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Results 
Sulfated proteoglycans are concentrated at the inner surface of the zymogen granule 
membrane 
To localise proteoglycans within zymogen granules at the ultrastructural level, pancreatic 
tissue and AR42J cells were stained using Cupromeronic Blue (CmB). CmB preferentially 
binds to highly sulfated acidic glycosaminoglycan side chains of proteoglycans (see Materials 
and Methods) (Fig. 1) and has been used successfully to stain proteoglycans in secretory 
granules of leucocytes (Unger et al. 1997). In ultrathin pancreatic sections CmB staining 
mainly appeared as elongated small electron-dense filaments or ‘prisms’ underneath the 
granule membrane with some variation between individual granules (Fig. 1A, B). CmB-
proteoglycan complexes were also observed in the intermembrane space (Fig. 1A), 
presumably due to a staining of proteoglycans of the extracellular matrix. Similar results were 
obtained with the exocrine cell line AR42J after treatment with the synthetic glucocorticoid 
dexamethasone, which is known to induce differentiation into acinar-like cells and the 
formation of secretory granules, which contain the major pancreatic zymogens (Logsdon et al. 
1985, Rinn et al. 2012). Electron-dense CmB-proteoglycan complexes were found underneath 
the granule membrane and in the intermembrane space, but were absent in controls treated 
with buffer (compare Fig. 1C and D). Those complexes were less prominent than in 
pancreatic granules, which may be explained by a lower concentration of proteoglycans in 
AR42J granules (which are much smaller than pancreatic zymogen granules; see Fig. 5) or by 
the presence of different proteoglycans (e.g. less sulphated ones). 
Next, we analyzed the distribution of granule marker proteins and proteoglycans in 
suborganellar fractions of zymogen granules. Isolated ZG from rat pancreas were separated in 
a content (ZGC) and membrane fraction (ZGM). Isolated ZGM were further treated with 
carbonate at pH 11.5 to liberate membrane-associated components (Borta et al. 2010, Schmidt 
et al. 2000) (Fig. 2A). Major soluble granule markers such as amylase or carboxypeptidase A 
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were predominantly found in the content fraction (ZGC, ~ 80%) and do not contribute much 
to the peripheral ZGM components (Borta et al. 2010). In contrast, the secretory lectin 
ZG16p, a peripheral ZGM protein (Borta et al. 2010, Cronshagen et al. 1994, Kleene et al. 
1999) which has recently been demonstrated to interact with heparan sulfate proteoglycans in 
ZG (Kumazawa-Inoue et al. 2012), was concentrated on isolated ZGM (~ 77%). However, 
most of the membrane-bound ZG16p (~ 68%) was removed by carbonate treatment (Fig. 2A), 
whereas GP2, a major GPI-anchored glycoprotein of ZG, was retained. In addition to ZG16p, 
~ 70% of the membrane-associated proteoglycans were removed by carbonate (Fig. 2B). 
Interestingly, we also observed an alteration of the migration of ZG16p in immunoblots of 
isolated ZGM. ZG16p is usually detected in a distinct protein band of about 16kD when the 
protein samples are heated at 95ºC prior to electrophoresis (Fig. 2C). However, incubation at 
RT results in a shift of the ZG16p band to the stacking gel indicating that the lectin is 
interacting with a large high molecular mass complex, which prevents it from entering the gel. 
In line with this, ZG16p and proteoglycans have been described as components of a 
submembranous protein matrix (Borta et al. 2010, Gómez-Lázaro et al. 2010, Schmidt et al. 
2000), which is supposed to aid in granule formation and protein sorting. 
Interestingly, electron microscopy of isolated ZGM and carbonate-treated ZGM fractions 
revealed that the untreated membranes appeared overwhelmingly curved or curled (Fig. 2D). 
In contrast, most of the carbonate-treated membranes had a strikingly linear appearance (Fig. 
2E). When immunogold electron microscopy with an anti-membrane matrix antibody was 
performed, gold labelling of peripheral ZGM components was predominantly found on the 
untreated, curved membranes (Fig. 2F). However, only few gold particles were visible on the 
linear membranes obtained after carbonate treatment (Fig. 2G).  
These observations suggest that peripheral ZGM components (as part of a membrane 
scaffold) may support the membrane shape and curvature of the relatively large ZG granules 
(1 µm in diameter). We assume based on the above observations that proteoglycans and 
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associated granule components have additional mechanical functions during granule 
formation at the TGN and for the maintenance of granule shape and stability. 
The carbonate extract was also subjected to agarose gel analysis (Fig. 3) and stained with 
toluidine blue, a dye which forms complexes with anionic glycoconjugates such as 
proteoglycans and glycosaminoglycans. A diffuse band and a high molecular smear indicative 
of proteoglycans/GAGs was detected in the ZGM extract. A minor portion of 
proteoglycans/anionic glycoconjugates was also found in the untreated ZGC fraction 
containing soluble content proteins. Carbonate treatment of this fraction revealed a larger 
amount of glycoconjugates which may become more accessible to agarose separation or dye 
staining. The inaccessibility might be due to a tight interaction with content proteins, which 
have to be removed before separation. It is possible that additional glycoconjugates are 
present within ZGs, which resist separation and staining according to the method described 
above. Despite several attempts (Kumazawa-Inoue et al. 2012) the nature of the proteoglycan 
core proteins within ZG has not yet been identified. 
 
Inhibition of proteoglycan synthesis perturbs granule formation in AR42J cells and 
pancreatic lobules 
To analyse the role of proteoglycans in granule formation in more detail, pancreatic AR42J 
cells were treated with 4-methylumbilliferyl-β-D-xyloside (β-D-xyloside) to inhibit 
proteoglycan synthesis (Suppl. Fig. S1). This drug blocks the formation of 
glycosaminoglycan chains on proteoglycans (Schwartz 1977). AR42J cells were pretreated 
with 2 mM β-D xyloside for 4 hours before granule formation was induced by the addition of 
10 nM dexamethasone (Fig. 4A-C). Normally, dexamethasone induces the differentiation of 
AR42J cells into acinar-like cells and the de novo formation of electron-opaque secretory 
granules, which contain the major pancreatic zymogens (Logsdon et al. 1985) (Fig. 1C, D 
and Fig. 4B). Interestingly, treatment with β-D-xyloside perturbed the formation of granules 
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in AR42J cells (Fig. 4C). Instead of the typical punctate staining pattern with numerous 
secretory granules labelled with carboxypeptidase A antibody (as shown in Fig. 4B; 60-70% 
of the cells show this staining), an unusual fine punctate staining pattern for carboxypeptidase 
A was observed in the majority of the cells (70-80%) (Fig. 4C). It has to be noted that the 
small punctate staining pattern was very characteristic for β-D xyloside treatment. Incubation 
of AR42J cells with mannosamine, an inhibitor of GPI anchor synthesis and N-glycosylation, 
for example, resulted in an accumulation of zymogens in the Golgi apparatus, and the 
formation of granular or fine punctate structures was completely inhibited (not shown). In 
unstimulated controls (without dexamethasone), 4-8% of the cells exhibited a strong labelling 
of the Golgi apparatus as well as a fine punctate staining pattern, which might represent 
constitutive cargo containers (Fig. 4A, Suppl. Fig. S2). 
Quantitative analysis of the morphological observations revealed that after β-D-xyloside 
treatment only 25% of the dexamethasone-stimulated cells exhibited a typical granular 
staining pattern, in contrast to ~ 65% in stimulated controls (Fig. 4D). Interestingly, the fine 
punctate staining pattern in β-D-xyloside-treated cells was more intense than in unstimulated 
controls (without dexamethasone) indicating that the expression of zymogens was induced 
(see also Fig. 8A) but normal granule formation was influenced.  
These observations were confirmed by ultrastructural studies (Fig. 5). In dexamethasone-
stimulated control cells electron-opaque secretory granules were observed in 72 ± 6% of the 
cells, whereas in unstimulated controls electron-dense granular structures were almost absent 
(4 ± 2% of the cells) (Fig. 5A, B). In β-D xyloside-treated cells electron-opaque granules 
were mainly absent as shown in Fig. 4D. However, electron-opaque granules could be 
identified in 12 ± 6% of the cells which appeared to be smaller than the secretory granules 
localized in the stimulated control cells (Fig. 5C). Therefore, the granule size was quantified 
for both, stimulated as well as β-D xyloside-treated cells, using unbiased sampling and sizing 
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methods (see Materials and Methods). The mean granule profile size was estimated to be 
125.8 nm in the stimulated control and 72.6 nm in β-D xyloside-treated cells (Fig. 5D). Those 
ultrastructural studies also confirmed the intactness of the cells after β-D xyloside treatment. 
The morphology of other intracellular organelles was unchanged when compared to untreated 
cells. 
Immunoblot analysis of fractions collected after density gradient centrifugation of cell 
homogenates revealed differences between secretory granules from controls and β-D 
xyloside-treated AR42J cells. We prepared continuous OptiPrep gradients (0-30%) from post 
nuclear supernatants of AR42J cells. We analysed equal amounts of protein of the fractions 
obtained after density gradient centrifugation by immunoblotting and quantified by 
densitometry (Fig. 6). Secretory granules from controls, identified by an antibody to amylase, 
were found mainly in gradient fractions 17-21 with some immunoreactivity in fractions 14-16. 
Some soluble amylase was also detected in the uppermost gradient fractions reflecting the 
fragmentation of granules during homogenization and centrifugation. However, amylase-
positive structures from β-D xyloside-treated cells exhibited a much broader distribution and 
were recovered in fractions 12-20 (Fig. 6). These data indicate that β-D xyloside treatment of 
dexamethasone-stimulated AR42J cells results in the formation of secretory organelles with 
different buoyant densities. This is in agreement with the ultrastructural studies indicating a 
shift towards smaller granule size in β-D xyloside treated cells (Fig. 5D). 
We also examined the effect of β-D-xyloside on granule morphology in rat pancreas (Fig. 
7). To investigate granule formation in the presence of inhibitor only, pancreas was first 
partially degranulated by feeding rats with a single dose of FOY-305 leading to a hormonally 
stimulated release of preexisting/stored zymogen granules (Rausch et al. 1987, Schmidt et al. 
2001). After degranulation pancreatic lobules were isolated, treated with β-D xyloside and 
processed for electron microscopy.  
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Ultrastructural studies of control and treated lobules provided evidence for the intactness 
and the polarity of the isolated acinar cells. Based on morphological criteria, the junctional 
complexes at the apical pole, the plasma membrane and membranes of intracellular organelles 
(Golgi, ER, mitochondria, granules) of the majority of the cells appeared intact after β-D 
xyloside treatment (compare Fig. 7A and B). Interestingly, granules exhibiting a strikingly 
irregular shape were observed in β-D-xyloside-treated cells, whereas the granules in controls 
had an overwhelmingly spherical appearance (Fig. 7). It has to be noted that the irregular-
shaped granules were also found distant from the Golgi complex in different locations of the 
apical region. It is likely that their formation is caused by β-D-xyloside treatment, and that 
they do not represent typical immature granules. Furthermore, some of the irregular-shaped 
granules were increased in diameter about 2-3-fold when compared to normal granules. This 
increase in size may be due to homotypic granule fusion. In addition, granular structures with 
an unusually small diameter (0.21 - 0.27 µm) were observed in β-D-xyloside-treated cells 
(Fig. 7D, insert, F). These findings are consistent with the results obtained in AR42J cells 
indicating that also in pancreatic lobules abnormal granules are formed in the presence of β-
D-xyloside. 
 
Treatment with β-D xyloside influences secretion of zymogens in AR42J cells 
We next examined whether treatment of AR42J cells with β-D xyloside had an impact on the 
induction and expression of zymogens induced by dexamethasone-treatment (Fig. 8A, B). 
Quantification of the cellular amount of amylase in controls (+/− dexamethasone) and 
inhibitor-treated cells verified that the observed effect of β-D xyloside on secretory granules 
was not due to differences in protein expression. Fig. 8A, B shows that addition of 
dexamethasone induces the expression of amylase in AR42J cells. The increase in the cellular 
Aroso et al. 18 
amount of amylase by dexamethasone-treatment is comparable in controls and β-D xyloside-
treated cells. 
 Dexamethasone not only induces secretory granule biogenesis, the expression and storage 
of amylase but it also sensitizes AR42J cells for stimulated exocytosis by up-regulation of 
CCK receptors (Logsdon 1986, Logsdon et al. 1985). To study whether the proteoglycan 
inhibitor β-D-xyloside had an impact on basal and stimulated secretion in AR42J cells, we 
determined the release of amylase under different conditions. Controls and cells treated with 
β-D-xyloside were stimulated for granule fomation with dexamethasone. After 48 hours cells 
were washed with Krebs-Hepes buffer and incubated with or without CCK-8. Supernatants 
and cell lysates were collected after 30 min and assayed for amylase activity (Fig. 8C, D). 
Interestingly, we observed a significant increase in the basal (unstimulated) secretion of 
amylase after treatment with β-D-xyloside (Fig. 8A). Stimulation with CCK induced amylase 
secretion in controls and β-D-xyloside-treated cells, but the ratio of stimulated vs. basal 
secretion was lower in β-D-xyloside-treated cells (Fig. 8B). These results further suggest that 
after β-D xyloside treatment part of the amylase is not located in typical, CCK-sensitive 
storage granules of AR42J cells and is constitutively secreted. 
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Discussion 
In this study we combined biochemical and morphological experiments using both AR42J 
cells and pancreatic tissue, which support the involvement of proteoglycans in the formation 
of normal-sized and stimuli-sensitive storage granules in acinar cells of the exocrine pancreas. 
Secretory granule biogenesis is a complex process involving the pH-dependent selective 
aggregation of regulated secretory proteins within the acidic environment of the TGN (for 
review see: Tooze et al. 2001; Dikeakos & Reudelhuber 2007; Bonnemaison et al. 2013) and 
the interaction of the aggregated zymogens with specific membrane domains. These sorting 
steps allow the separation of regulated secretory proteins from constitutively released cargo 
and their packaging in a concentrated form within secretory granules. In contrast to the well 
documented selective aggregation of the complex mixture of zymogens in pancreatic acinar 
cells (Dartsch et al. 1998, Freedman & Scheele 1993, Leblond et al. 1993), relatively little 
information is available on the specific interaction of zymogens with the TGN/granule 
membrane and their ultimate sorting (Dikeakos & Reudelhuber 2007, Gómez-Lázaro et al. 
2010, Schrader 2004). However, there is evidence that specific accessory or ‘helper’ 
molecules including proteoglycans, sulfated glycoproteins and lectins support exocrine 
granule formation (de Lisle 2002, Forsberg et al. 1999, Kleene et al. 1999, Leblond et al. 
1993). Expression of the sulfated mucin-type glycoprotein pro-Muclin, for example, has been 
shown to induce granule size in AR42J cells (de Lisle et al. 2005).  
A role for proteoglycans in the homeostasis and storage of proteases and amines in 
secretory granules has been well studied in mast cells (Rönnberg et al. 2012, Wernersson & 
Pejler 2014). For the exocrine pancreas, however, studies showing the presence of 
proteoglycans in ZGs have so far been descriptive only. In vitro studies suggested that 
sulfated proteoglycans within ZGs might mediate the sorting and aggregation of cationic 
zymogens via ionic interactions of their negatively charged sulfate groups (Reggio & Dagorn 
1978, Reggio & Palade 1978, Tartakoff et al. 1975). Using the CmB protocol as well as gel-
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based analyses, we provided direct morphological and biochemical evidence for the presence 
of proteoglycans within the ZGs of rat pancreas. Interestingly, the majority of the 
proteoglycans appears to be associated with the ZG membrane, since CmB-proteoglycan 
complexes were detected predominantly underneath the granule membrane. This is consistent 
with biochemical findings, where the majority of sulfate-labeled proteoglycans in pancreatic 
acinar cells of the rat were found to be associated with ZG membranes and could be released 
by carbonate treatment (Scheele et al. 1994, Schmidt et al. 2000) (see Fig. 2). Furthermore, 
the lectin ZG16p, which has been shown to interact with proteoglycans (Kumazawa-Inoue et 
al. 2012), is mainly localised at the ZG membrane and interacts with a large high molecular 
mass complex liberated from ZG membranes. In contrast to ZG, CmB-proteoglycan 
complexes in secretory granules of leucocytes were found to be distributed over the whole 
granule (Unger et al. 1997).  
We and other groups have put forward the hypothesis that specific proteoglycans (and 
associated components) form a submembranous protein scaffold (submembranous matrix) at 
the luminal side of the granule membrane, which functions in membrane targeting of 
zymogens as well as in granule formation and stability (Borta et al. 2010, Freedman et al. 
1998, Kleene et al. 1999, Scheele et al. 1994, Schmidt et al. 2000, 2001; Schrader 2004). Our 
ultrastructural data further support the existence of such a membrane-associated protein 
matrix. The striking loss of membrane shape and curvature after removal of proteoglycans 
and other matrix components by carbonate treatment of isolated ZG membranes implies that 
the submembranous protein scaffold has an influence on granule shape, structure and stability 
(Fig. 9). This notion is further supported by the appearance of irregular-shaped granules after 
the inhibition of proteoglycan synthesis by treatment of pancreatic lobules with β-D-xyloside.  
Interestingly, proteoglycans were also required for the dexamethasone-induced formation 
of normal ZGs in AR42J cells. It is likely that proteoglycans contribute to the proper 
packaging, concentration and sorting of zymogens into secretory granules (Fig. 9), since 
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treatment of AR42J cells with β-D-xyloside reduced the appearance of electron-dense 
secretory granules and resulted in the formation of granule structures with a smaller size. 
After density centrifugation those structures exhibited a much broader distribution and thus, 
different buoyant densities when compared to control cells. However, amylase expression was 
not reduced in β-D-xyloside-treated cells when compared to controls. These findings are 
indicative for the formation of smaller secretory organelles and/or a reduction in the amount 
of cargo in the presence of β-D-xyloside.  
In support of this, it has been reported, that mast cells from mice with a defect in heparin 
synthesis contained smaller granules and large empty vacuoles and failed to store several 
proteins that are normally bound to heparin in secretory granules (Forsberg et al. 1999, 
Humphries et al. 1999). A reduction in cargo can be explained by inefficient aggregation, 
packaging and sorting/membrane targeting of zymogens. However, proteoglycans may 
display multiple functions during granule formation (Fig. 9). The membrane-associated 
proteoglycans can function not only as a submembranous scaffold for the attachment of 
zymogen complexes, but also as a mechanical device for membrane deformation at the TGN 
(Huttner & Zimmerberg 2001), and maintenance of granule size. The impairment of such a 
mechanical function could also contribute to the formation of smaller secretory organelles 
instead of normal-sized granules.  
Furthermore, the basal secretion of amylase was increased in AR42J cells after β-D-
xyloside treatment. This might be indicative for misrouting of secretory proteins to a 
constitutive pathway and is in line with the morphological observations, e.g. the appearance 
of abnormal granules and/or non-granular, presumably constitutive transport containers.  
It should be noted that regardless of the absence or presence of serglycin proteoglycans, the 
major constituents in mast cells, granules are of about equal size and are present in 
approximately equal numbers (Åbrink et al. 2004, Braga et al. 2007, Wernersson & Pejler 
2014). Although serglycin is crucial for dense core formation and supports storage of granule 
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compounds it does apparently not contribute to the biogenesis of mast cell granules in the 
systems studied. This appears to be in contrast to ZG granules, and might be explained by the 
predominant membrane-association of proteoglycans in ZGs. The glycosaminoglycan side 
chains of heparin sulphate proteoglycans from rat pancreatic ZG were recently characterized 
by Kumazawa-Inoue and colleagues (Kumazawa-Inoue et al. 2012). Furthermore, the 
digestion of those proteoglycans with heparin lyase II exposed the core proteins having a 
molecular weight of 66 and 35-40 KDa, but the identification of the core protein was 
unsuccessful. Nevertheless, serglycin is not supposed to be present in ZG or to contribute to 
ZG biogenesis in mice (Niemann et al. 2009). On the other hand, several ZG components 
have been identified which can interact with proteoglycans including the lectin ZG16p, the 
chymase mast cell protease 1, PpiB (peptidyl-prolyl cis-trans isomerase B), CEL and RNase 
A. Interestingly, those proteins have been found to be associated with the ZG membrane 
(Borta et al. 2010, Chen et al. 2008). Thus, proteoglycans might be involved in their 
sorting/packaging to ZG (Fig. 9). In addition, the interaction with proteoglycans is supposed 
to influence enzyme function, which might be important after secretion (Pejler & Sadler 
1999) Proteoglycans have also been found associated with detergent-insoluble 
cholesterol/glycolipid-enriched complexes of the ZG membrane (Kalus et al. 2002, Schmidt et 
al. 2001). If they contribute to the clustering of lipid raft components and to the assembly of 
functional protein complexes (Ikonen 2001), and thus, influence granule fusion, has to be 
elucidated (Fig. 9). In line with this, proteoglycans may have a role in facilitating ZG 
maturation by regulating the removal of membranes via clathrin-mediated processes. This 
would be consistent with an increase in granule size observed for some ZG in the exocrine 
pancreas (Fig. 7). 
We propose that proteoglycans within ZG are important accessory components in granule 
biogenesis which can support multiple steps in granule formation (Fig. 9): ZG proteoglycans 
are able to interact electrostatically and through specific protein-protein and carbohydrate-
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protein binding domains with the secretory proteins of the granule content (Scheele et al. 
1994, Schmidt et al. 2000, Schrader 2004). In addition to a potential mechanical function in 
granule formation and in the maintenance of granule shape and stability, they contribute to the 
proper packaging and sorting/membrane binding of zymogens (Fig. 9). Additional functions 
may be the modulation of enzyme function before or after secretion and granule 
fusion/exocytosis. It will be a challenge for future studies to identify and characterize these 
proteoglycans, and to elucidate their complex functions and interactions in health and disease. 
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Figure legends 
Figure 1. Pancreatic zymogen granules possess a submembranous proteoglycan scaffold. 
Pancreatic tissue (A-C) and AR42J cells (D, E) were stained according to the Cupromeronic 
Blue (Cmb) protocol and embedded for electron microscopy (see Materials and Methods). (A) 
Control treated with buffer without Cmb. (B, C) Electron dense proteoglycan complexes were 
found to form filaments or ‘prisms’ underneath the granule membrane in acinar cells of rat 
pancreas (B; asterisks) and in AR42J cells (D; white arrows). In addition, Cmb staining was 
detected within the intracellular space (B, D; black arrows). (C) Higher magnification of 
zymogen granules in acinar cells of rat pancreas after Cmb staining. Arrows point to 
proteoglycan complexes. (E) AR42J control treated with buffer without Cmb. Note that in 
controls no staining is detectable underneath the granule membrane. Bars, 1 µm. 
 
Figure 2. Membrane-associated proteoglycans and granule matrix components influence 
membrane curvature. (A) Zymogen granules (ZG) were isolated from rat pancreas, and 
granule subfractions were prepared as described in Materials and Methods. Lysed granules 
were separated into a content (ZGC) and membrane fraction (ZGM). In addition, isolated 
membranes were treated with carbonate and separated into a pellet (P, treated membranes) 
and supernatant (Sup, carbonate-extract) fraction. Equivalent amounts were analysed by 
SDS-PAGE and immunoblotting, using antibodies against carboxypeptidase A (carb), 
amylase (amyl), ZG16p and GP2. (B) The amount of proteoglycans (PG) in the supernatant 
(Sup) and pellet (P) fractions obtained after carbonate treatment of ZGM was determined with 
the Blyscan assay. The results are expressed as percent of total proteoglycans (supernatant + 
pellet fraction). (C) Immunoblotting of ZG membranes (ZGM) using anti-ZG16p antibody. 
Protein samples were heated at 95ºC or incubated at room temperature (RT). Note the 
accumulation of ZG16p in the stacking gel (dotted line). (D-G) Ultrastructure of isolated ZG 
membranes. Isolated membranes (ZGM) were either left untreated (D, F) or incubated with 
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carbonate (E, G) to remove granule matrix components, and afterwards processed for electron 
microscopy. (F, G) Immunogold electron microscopy of isolated membranes incubated with a 
polyclonal anti-matrix antibody and visualized using 10-nm protein A-gold. Note the 
overwhelmingly curved (arrowheads) or curled membranes (arrows) in (D, F), in contrast to 
their linear appearance in (E, G), and the reduced number of gold particles at the membranes 
in (G). Con, control. Bars, 1 µm.  
 
Figure 3. Detection of glycoconjugates in zymogen granule subfractions. Zymogen 
granules were isolated from rat pancreas, and membrane (ZGM) and content fractions (ZGC) 
were prepared. Isolated ZGM and ZGC were treated with carbonate and the supernatants 
(carb) collected after centrifugation. Samples were afterwards separated on 1% agarose gels 
and stained with toluidine blue. 1 mg (ZGC; ZGCcarb) and 500 µg (ZGMcarb) of protein 
were applied per lane. Chondroitin sulfate and biglycan were used as standards. 
 
Figure 4. Inhibition of proteoglycan synthesis perturbs granule formation in AR42J 
cells. AR42J cells were cultured in the absence (A) or presence of dexamethasone (B, C). 
Cells in (C) were also treated with 2 mM β-D-xyloside (b-D-xyl). Images show 
immunostaining with an antibody directed against carboxypeptidase A. Note the presence of 
typical punctate granules in (B), in contrast to their absence in (A) and (C). Arrows in (A) and 
(C) point to cells exhibiting an unusual fine punctate staining pattern. Higher magnification 
images of boxed regions are shown in (A) and (C). Bars, 10 µm. (D) Quantitative analysis of 
granular staining after the different treatments (see Materials and Methods). The data are from 
4-6 independent experiments and are expressed as means ± S.D. (* p<0.01 when compared to 
dexamethasone-stimulated controls (Con)). (+) with or (-) without dexamethasone (dexa). 
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Figure 5. Presence of secretory granules in AR42J cells after treatment with β-D-
xyloside and dexamethasone. AR42J cells were cultured under the experimental conditions 
described in Fig. 4 and processed for electron microscopy (see Materials and Methods). Note 
the presence of electron-opaque secretory granules in (A, arrows, mean granule size 125.8 
nm, n = 93), in contrast to their absence in (B). After treatment with β-D-xyloside (xyl) small 
granules can be seen clustered around the Golgi region (C, mean granule size 72.6 nm, n = 
107). (D) Granule size distribution. Granules were sampled using an unbiased scanning band 
and sizes estimated through counting line intersections of granule profiles with a 
systematically spaced graticule. G, Golgi apparatus; (+) with or (-) without dexamethasone 
(dexa). Bars, 500 nm in overview, 200 nm in enlargement. 
 
Figure 6. Secretory vesicles isolated from β-D-xyloside-treated AR42J cells and controls 
show different buoyant densities. Dexamethasone-stimulated AR42J cells were either 
treated with β-D-xyloside (xyl) or left untreated (control). After 48 hours cells were 
homogenized, and the postnuclear supernatant was subjected to density gradient 
centrifugation. Fractions were collected from the top of the gradient and analyzed by SDS-
PAGE and immunoblotting. The presence of amylase in the gradients is shown as a 
densitometric diagram measured from the immunoblots.  
 
Figure 7. Fine structure of pancreatic lobules after treatment with β-D-xyloside. 
Pancreatic lobules were incubated in the absence (A, C) or presence (B, D) of β-D-xyloside 
(b-D-xyl). After 3 hours lobules were fixed, embedded in Epon and processed for electron 
microscopy as described in Materials and Methods. (A, C) Control lobules (Con). Note the 
presence of junctional complexes (arrows) and the apical localization of zymogen granules. 
(B, D) After β-D-xyloside treatment individual Golgi cisternae had a dilated appearance. 
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Irregular-shaped zymogen granules (asterisks) as well as unusually small granules (D, insert) 
were frequently observed. (E, F) Quantification of irregular-shaped granules (E) and 
unusually small granules (0.21 - 0.27 µm in diameter) (F) in controls and after β-D-xyloside 
treatment. Data are expressed as means ± S.D. (* p<0.01 when compared to controls (Con), 
n= 1011-1251 from 95-107 cells). G, Golgi apparatus; L, acinar lumen. Bars, 5 µm (A, B), 1 
µm (C, D).  
 
Figure 8. Effect of β-D-xyloside on amylase secretion in AR42J cells. (A) Expression of 
amylase in AR42J cells. Cells were treated with 2 mM β-D-xyloside (bDXyl) or DMSO 
(Con) and cultured in the absence (-) or presence (+) of dexamethasone to induce granule 
formation. After 48h, cells were lysed and equal amounts of protein were separated by SDS-
PAGE and immunoblotted using antibodies directed to amylase and tubulin. (B) 
Densitometric quantification of immunoblots in (C) of total amylase normalized to tubulin. 
(C, D) Effect of β-D-xyloside on amylase release. Cells were washed with Krebs-Hepes 
buffer (KHB) and incubated with (CCK) or without CCK-8 (KHB) for 30 min. Supernatants 
and cell lysates were collected and assayed for amylase activity. Values for amylase release in 
(C) are expressed as percentage of the total cellular amylase. Note the increased basal 
secretion of amylase in β-D-xyloside treated cells (C) and the lower ratio of stimulated vs. 
basal secretion (D). Fold-stimulation was calculated as the secreted amount in the presence of 
CCK-8 divided by the secreted amount in the absence of CCK-8. Data are presented as means 
± S.D. from 3 independent experiments. 
 
Figure 9. Potential functions of proteoglycans during zymogen granule biogenesis and 
secretion. During the generation of immature ZG at the TGN, a proteoglycan scaffold at the 
TGN/granule membrane can support granule formation by promoting membrane curvature 
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and can aid in the sorting and packaging of zymogens (①). Proteoglycans are supposed to 
interact with membrane components, e.g. GP2, a major GPI-anchored glycoprotein of ZG and 
are associated with lipid microdomains of the granule membrane. Proteoglycans can 
contribute to dense core formation and maturation of granules (②). The lectin ZG16p can 
potentially bridge interactions between proteoglycans and cargo proteins. During exocytosis, 
the proteoglycan-cargo meshwork is released into the acinar lumen and the pancreatic duct 
system (③). During this process, certain cargo molecules may detach (due to changes in pH) 
whereas others remain associated. This can have an impact on enzyme function (④). Certain 
complexes may bind to the surface of duct cells or enterocytes after secretion. CV, 
condensing vacuole; ISG, immature secretory granule; ZG, zymogen granule; ZGM, ZG 
membrane; ZGC, ZG content; ZGMcarb, carbonate-treated ZG membranes. 
 
 
Supplementary Material 
Supplementary Figure S1. Inhibition of proteoglycan synthesis in AR42J cells. 
Dexamethasone-stimulated AR42J cells were treated with different concentrations of β-D-
xyloside (b-D-xyl) (0-2.5 mM) for 48 hours, and the relative amounts of precipitable 
proteoglycans in cell homogenates were analyzed using the Blyscan assay. The data are from 
4 independent experiments and are expressed as means ± S.D.  
 
Supplementary Figure S2. Co-localisation of carboxypeptidase A and the Golgi marker 
p115 in unstimulated AR42J cells. Unstimulated AR42J cells (- dexa) were processed for 
immunofluorescence and stained with antibodies directed against the Golgi marker protein 
p115 (A) and the granule enzyme carboxypeptidase A (CBP A) (B). Note the co-localisation 
of both proteins at the Golgi complex (arrows) and the presence of fine punctate structures 
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positive for carboxypeptidase A, which may represent constitutive cargo containers (B). Bar, 
10 µm. 
